Intention notice: Subcutaneous infusion sets for continuous subcutaneous drug delivery

rtified for various medicines used in the treatment of Parkinson’s Disease, Immune Deficiencies, Pain Management and Thalassaemia. The product series is called Neria manufactered by Convatec. The framework agreement will have a duration of two years with an option for a further 1+1 year extension.

Sykehusinnkjøp HF intends, on behalf of the regional health authorities in Norway (with underlying health companies), to enter into a framework agreement with Nordic Infucare AS for subcutaneous infusion sets that are ce